Evidence map›Paper›PMID 9592157›Full record

ArticleNucleic acids research1998

DNA binding and transcription activation specificity of hepatocyte nuclear factor 4.

J D Fraser, V Martinez, R Straney, M R Briggs

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Farnesoid X receptor represses hepatic human APOA gene expression.The Journal of clinical investigation · 2011
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J D FraserLigand Pharmaceuticals Inc., 10255 Science Center Drive, San Diego, CA 92121, USA. jfraser@ligand.com
V Martinez
R Straney
M R Briggs
Ligand Pharmaceuticals (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocyte nuclear factor 4 (HNF-4) is an orphan intracellular receptor that appears to be a key factor in the regulation of energy metabolism. In order to gain greater understanding of the binding and activation requirements of HNF-4, we performed genetic analysis of the apoCIII promoter, a promoter that has previously been shown to be highly sensitive to HNF-4-induced transcription. We identified two elements within the apoCIII promoter that bind HNF-4, either of which are sufficient to confer promoter induction in response to HNF-4. These two elements are both direct repeat-like in nature, but they differ significantly in motif sequence and the repeats are separated by either 1 or 2 nt. Therefore, to better define the DNA sequence recognition requirements of HNF-4, we utilized PCR-based binding site selection. HNF-4 selected for direct repeat-like elements with either 1 or 2 nt between the repeats. Surprisingly, the strongest selection was for a core motif that included the nucleotides between the repeats. Mutation of the nucleotide between the repeats resulted in a 6-fold reduction in affinity, indicating that the interaction between HNF-4 and the intervening nucleotide(s) is critical for high affinity binding.

Indexed as

Promoter Regions, GeneticTranscriptional ActivationApolipoprotein C-IIIApolipoproteins CBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsDNADNA-Binding ProteinsHepatocyte Nuclear Factor 4HumansPhosphoproteinsReceptors, Cytoplasmic and NuclearTranscription FactorsTumor Cells, CulturedApolipoprotein C-IIIApolipoproteins CBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsDNADNA-Binding ProteinsHepatocyte Nuclear Factor 4MLX protein, humanPhosphoproteinsReceptors, Cytoplasmic and NuclearTranscription Factors

Identifiers

PMID9592157
PMCPMC147588
OpenAlexW2105092737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.